Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | CFTR | P13569 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALPG | P10696 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | NPY1R | P25929 | 1/20 | 0.44 |
| ▸ | NPY2R | P49146 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28284821 | 0.97 | ESR1 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL115791 | 0.84 | ESR1 (0.71) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL25435946 | 0.81 | ESR1 (0.68) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL18892991 | 0.80 | ESR1 (0.43) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL28448983 | 0.79 | ESR1 (0.52) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL29976023 | 0.78 | HDAC8 (0.46) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL19732114 | 0.77 | ESR1 (0.50) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL482384 | 0.77 | ESR1 (0.50) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL19353458 | 0.77 | CA2 (0.62) | ESR1CA2CA4CA5AALDH1A1 | |
| SCHEMBL11427765 | 0.77 | ESR1 (0.50) | ESR1CA2CA4CA5AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 387 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024240118-A1 | PREPARATION FOR AND USE OF HETEROARYL DERIVATIVES | 广州智睿医药科技有限公司 | 2024-11-28 | — | — | WO | claimed |
| CN-119019454-A | Preparation and application of heteroaryl derivative | 广州智睿医药科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-111163922-B | Natural rubber mould-free manufacturing method | 国家科学技术发展局 | 2023-03-14 | — | — | CN | claimed |
| US-20220402948-A1 | EGFR INHIBITOR, COMPOSITION AND PREPARATION METHOD THEREFOR | BETTA PHARMACEUTICALS CO., LTD. (CN) | 2022-12-22 | — | — | US | claimed |
| EP-2481760-B1 | INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION AND POLYMERIZATION METHOD USING SAME | CHINA PETROLEUM & CHEM CORP (CN) | 2021-05-05 | — | — | EP | claimed |
| US-20210020838-A1 | COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND QUANTUM DOT LIGHT-EMITTING DIODE | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2021-01-21 | — | — | US | claimed |
| US-20210020858-A1 | COMPOSITE MATERIAL AND QUANTUM DOT LIGHT EMITTING DIODE | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2021-01-21 | — | — | US | claimed |
| CN-110885674-A | Composite material and preparation method thereof | TCL集团股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| CN-110890469-A | Composite material and preparation method thereof | TCL集团股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| EP-2403642-B1 | METHODS OF USING A SELECTIVE HYDROGENATION CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2017-08-02 | — | — | EP | claimed |
| US-4155932-A | REACTING CHLORINE AND CARBON MONOXIDE WITH A TERTIARY PHOSPHINE OXIDE | UBE INDUSTRIES, INC. (JP) | 1979-05-22 | — | — | US | claimed |
| US-4066690-A | CHEMICAL INTERMEDIATES FOR PROSTAGLANDINS | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-01-03 | — | — | US | claimed |
| US-4013715-A | PROCESS FOR THE MANUFACTURE OF 2-HALO-ETHANE-PHOSPHONIC ACID DIHALIDES AND VINYL-PHOSPHONIC ACID DIHALIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | claimed |
| EP-3719042-B1 | METHOD FOR PRODUCING STYRENE RESIN AND STYRENE RESIN MOLDED ARTICLE | IDEMITSU KOSAN CO (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| US-20250051500-A1 | RADIATION-CURABLE COMPOSITION | MARABU GMBH & CO. KG (DE) | 2025-02-13 | — | — | US | disclosed |
| US-4013715-A | PROCESS FOR THE MANUFACTURE OF 2-HALO-ETHANE-PHOSPHONIC ACID DIHALIDES AND VINYL-PHOSPHONIC ACID DIHALIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | disclosed |
| US-3962326-A | CARBOXYLIC ACID OR ANHYDRIDE, PHOSGENE, TRISUBSTITUTED PHOSPHINE OXIDE OR SULFIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
| US-3962324-A | Process for preparing halogenomethane-phosphonic acid dihalides | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
| US-3952099-A | MICROBIOCIDE, SUGAR ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | GSDMD, PIGS, GANC | ESR1 4082/4885CA2 1062/4885CA4 908/4885 |
| US-20220402948-A1 | EGFR INHIBITOR, COMPOSITION AND PREPARATION METHOD THEREFOR | EGFR, ERBB2, ERBB3 | ESR1 242/4885CA2 2746/4885CA4 2322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.